This briefing details the FDA-cleared ER-100 gene therapy trial using truncated Yamanaka factors for ocular age reprogramming, highlighting…
OpenAI’s retirement of GPT-4o by 2026 highlights AI safety challenges from engagement-driven model design, legal liabilities including wrongful-death…
OpenAI’s retirement of GPT-4o marks a shift from static LLMs to dynamic, programmable AI services with fine-grained customization,…
Analysis of Elon Musk’s planned SpaceX IPO and xAI merger to create vertically integrated orbital AI data centers…

This briefing analyzes generative AI adoption in cybercrime, revealing low-skill actors’ distrust and preference for manual, trust-based methods.…
Analysis of how a founder’s online behavior, amplified by platform algorithms, pseudonymous identities, and AI-mediated content like Grok,…